Poster & Publications

Prognostic value of circulating nucleosomes during treatment with or without immunotherapy in Non-Small Cell Lung Cancer: results from Nucleo-Lung study

September 14, 2024

Share
Tweet
Share on Facebook
Share

Poster titled: Prognostic value of circulating nucleosomes during treatment with or withoutimmunotherapy in Non-Small Cell Lung Cancer: results from Nucleo-Lung study

Presented at: ESMO 2024

Payen et al

Download

Poster & Publications
Nu.Q® NETs immunoassay detects Neutrophil Extracellular Traps by quantifying circulating H3.1 nucleosomes
Videos
How to use the Nu.Q® H3.1 Test

Share
Tweet
Share on Facebook
Share

Subscribe for Volition product updates.

Or, click here for Investor Updates and press releases.

"*" indicates required fields

Receive product updates for:

Animal Health

Human Health

Name*

First Name Last Name

Company Name*

Your Email Address*

CAPTCHA

Prognostic value of circulating nucleosomes during treatment with or without immunotherapy in Non-Small Cell Lung Cancer: results from Nucleo-Lung study

Related Articles

Nu.Q® NETs immunoassay detects Neutrophil Extracellular Traps by quantifying circulating H3.1 nucleosomes

How to use the Nu.Q® H3.1 Test

Subscribe for Volition product updates.

Or, click here for Investor Updates and press releases.

Contact